Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome

<p><strong>Methodology</strong> This guideline was compiled according to the British Society for Haematology (BSH) process at (http://www.bcshguidelines.com). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) nomenclature was used to evaluate levels of e...

Full description

Bibliographic Details
Main Authors:	Tunstall, O, Bhatnagar, N, James, B, Norton, A, O'Marcaigh, AS, Watts, T, Greenough, A, Vyas, P, Roberts, IAG, Wright, M
Format:	Journal article
Published:	Wiley 2018

Similar Items

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
by: Vyas, P, et al.
Published: (2007)

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
by: Bhatnagar, N, et al.
Published: (2016)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
by: Roy, A, et al.
Published: (2009)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
by: Norton, A, et al.
Published: (2007)

Natural history of GATA-1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2003)

Natural history of GATA1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2004)

Haematopoietic development and leukaemia in Down syndrome
by: Roberts, I, et al.
Published: (2014)

Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
by: Roy, A, et al.
Published: (2012)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
by: Garnett, C, et al.
Published: (2019)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Transient abnormal myelopoiesis without constitutional Down syndrome
by: Kairiene, I, et al.
Published: (2019)

Most haematological abnormalities in neonates with Down syndrome are transient but dysplastic myelopoiesis persists throughout early childhood
by: Hanssen, L, et al.
Published: (2019)

Haematology of Down syndrome.
by: Webb, D, et al.
Published: (2007)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
by: Craze, J, et al.
Published: (1999)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
by: Hasle, H, et al.
Published: (2008)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
by: Tunstall-Pedoe, O, et al.
Published: (2008)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
by: Vyas, P, et al.
Published: (2006)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
by: Vyas, P, et al.
Published: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

Down syndrome preleukemia and leukemia.
by: Maloney, K, et al.
Published: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
by: Maroz, A, et al.
Published: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
by: Maroz, A, et al.
Published: (2014)

Trisomy 21 expands the megakaryocyte-erythroid progenitor compartment in human fetal liver-implications for down syndrome AMKL.
by: Tunstall-Pedoe, O, et al.
Published: (2006)

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
by: Chessells, J, et al.
Published: (2001)

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
by: Oscier, D, et al.
Published: (2012)

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
by: Patrick, K, et al.
Published: (2014)

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol
by: Patrick, K, et al.
Published: (2014)

Infantile acute megakaryoblastic leukaemia with T(1:22) in a non-down syndrome child.
by: Nurasyikin Y,, et al.
Published: (2012)

Molecular insights into Down syndrome-associated leukemia.
by: Vyas, P, et al.
Published: (2007)

Acute leukemias in children with Down syndrome.
by: Zwaan, C, et al.
Published: (2010)

Acute leukemias in children with Down syndrome.
by: Zwaan, M, et al.
Published: (2008)

Myeloid pre-leukemia and leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
by: Heald, B, et al.
Published: (2007)

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
by: Gurbuxani, S, et al.
Published: (2004)

Frequent cases of RAS-mutated down syndrome acute lymphoblastic leukaemia lack JAK2 mutations
by: Nikolaev, Sergey I., et al.
Published: (2014)